OPTOLANE Technologies, Inc.

[Not Yet Scheduled]
OPTOLANE Technologies, Inc. has developed a CMOS photo-sensor-integrated Point-of-Care molecular platforms, which is called LOAA (lab on an array). The LOAA enables to do a digital real-time PCR and a high multi-test PCR with an unprecedented easy and simple way. This innovative platforms have great potential for applications including clinical diagnostics, a novel drug discovery, genomic and proteomic research, genetic disorder, viral load, liquid biopsy such as cancer diagnostics and prognosis, process quality control monitoring and etc.

The key differentiating features of LOAA platform are its high sensitivity, compact, easy-of-use and connectivity. These features will help researchers to establish an early-warning, decentralized diagnostic surveillance system and will greatly accelerate healthcare professionals to monitor patient’s status, identify causes of disease, select appropriate treatments, prevent a transmission of an emerging disease.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2012
Main Therapeutic Focus:
Lead Product in Development:
LOAA digital PCR and real-time PCR system
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
CEO
OPTOLANE Technologies, Inc.